Cytosorbents Corp (NASDAQ:CTSO)’s traded shares stood at 1.07 million during the latest session, with the company’s beta value hitting 1.13. At the last check today, the stock’s price was $0.90, to imply a decrease of -10.99% or -$0.11 in intraday trading. The CTSO share’s 52-week high remains $1.61, putting it -78.89% down since that peak but still an impressive 22.22% since price per share fell to its 52-week low of $0.70. The company has a valuation of $56.29M, with an average of 77610.0 shares in intraday trading volume over the past 10 days and average of 103.51K shares over the past 3 months.
Cytosorbents Corp (NASDAQ:CTSO) trade information
After registering a -10.99% downside in the latest session, Cytosorbents Corp (CTSO) has traded red over the past five days. The 5-day price performance for the stock is -18.27%, and -10.10% over 30 days. With these gigs, the year-to-date price performance is -1.21%. Short interest in Cytosorbents Corp (NASDAQ:CTSO) saw shorts transact 1.62 million shares and set a 22.01 days time to cover.
An assessment of the company’s 5-year growth patterns shows that annual earnings grew an estimated 8.62% for the past 5-year period. While 2025 is set for a 2.17% return in earnings, projections for the next 5 years are at 52.28% annually.
CTSO Dividends
Cytosorbents Corp has its next earnings report out on 2025-Mar-30. However, it is important to take into account that this dividend yield ratio is just an indicator to only serve the purpose of guidance. Investors interested to invest in the stock should ponder company’s other fundamental and operations related aspects too.
Cytosorbents Corp (NASDAQ:CTSO)’s Major holders
Cytosorbents Corp insiders hold 8.51% of total outstanding shares, with institutional holders owning 26.45% of the shares at 28.91% float percentage. In total, 26.45% institutions holds shares in the company, led by AVENIR CORP. As of 2024-06-30, the company held over 2.97 million shares (or 5.4695% of shares), all amounting to roughly $2.09 million.
The next major institution holding the largest number of shares is SKYLANDS CAPITAL, LLC with 2.84 million shares, or about 5.2311% of shares outstanding. As of the market price on 2024-06-30, these shares were worth $2.0 million.
We also have VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and NEUBERGER BERMAN EQUITY FUNDS-Neuberger Berman Intrinsic Value Fund as the top two Mutual Funds with the largest holdings of the Cytosorbents Corp (CTSO) shares. Going by data provided on Dec 31, 2024 , VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund holds roughly 1.3 shares. This is just over 2.08% of the total shares, with a market valuation of $1.16 million. Data from the same date shows that the other fund manager holds a little less at 726.14, or 1.16% of the shares, all valued at about 0.65 million.
